ETON
$50.19+1.97%
Eton Pharmaceuticals Inc.Stock · HealthcareRussell 2000 · 0.03% of IWMRussell 3000 · 0.002% of IWVUS Stock Market · 0.001% of VTI
ETON financial statements
The full income statement, balance sheet, and cash-flow statement for Eton Pharmaceuticals Inc. (ETON), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 25.8M2024-09 25.8M2024-12 26.8M2025-03 26.8M2025-06 26.8M2025-09 26.8M2025-12 27.3M2026-03 27.4M2026-06 28.6M+10.6% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 80.0M+104.9% | 39.0M+23.3% | 31.6M+48.9% | 21.3M-2.7% | 21.8M+55879.5% | |
| 42.7M+82.6% | 23.4M+11.2% | 21.1M+47.1% | 14.3M-24.7% | 19.0M+4887.2% | ||
| Cost of revenue | 37.2M+138.5% | 15.6M+47.4% | 10.6M+52.6% | 6.93M+145.2% | 2.83M+548.4% | |
| 43.6M+67.6% | 26.0M+16.9% | 22.3M-1.4% | 22.6M+10.1% | 20.5M-23.3% | ||
| Research & development | 7.76M+138.6% | 3.25M-2.0% | 3.32M-16.9% | 4.00M-35.9% | 6.24M-55.8% | |
| Selling, general & administrative | 35.8M+57.4% | 22.8M+20.2% | 18.9M+1.9% | 18.6M+30.3% | 14.3M+13.1% | |
| General & administrative | 35.8M+57.4% | 22.8M+20.2% | 18.9M+1.9% | 18.6M+30.3% | 14.3M+13.1% | |
| Amortization of intangibles | 4.00M+265.2% | 1.10M+38.7% | 790K-51.1% | 1.62M+692.6% | 204K+36.0% | |
| Operating income | -844K+67.5% | -2.60M-117.9% | -1.19M+85.6% | -8.26M-452.5% | -1.50M+94.5% | |
| Interest expense | 4.78M+138.5% | 2.00M+89.2% | 1.06M+11.0% | 955K-8.3% | 1.04M+17.9% | |
| Other non-operating income | -3.71M-206.7% | -1.21M-340.8% | 503K+166.1% | -761K+24.4% | -1.01M-17.1% | |
| Pre-tax income | -4.56M-19.7% | -3.81M-452.7% | -689K+92.4% | -9.02M-361.4% | -1.96M+93.0% | |
| Income tax | 43.0K+186.7% | 15.0K-93.9% | 247K | 0.00 | 0.00 | |
| Net income | -4.60M-20.4% | -3.82M-308.4% | -936K+89.6% | -9.02M-361.4% | -1.96M+93.0% | |
| EPS (basic) | -$0.17-13.3% | -$0.15-275.0% | -$0.04+88.9% | -$0.36-350.0% | -$0.08+94.0% | |
| Weighted-avg shares (basic) | 26.9M+3.9% | 25.9M+1.0% | 25.6M+2.0% | 25.1M-0.2% | 25.2M+20.0% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 60.6M+47.7% | 41.0M+52.8% | 26.8M+34.2% | 20.0M-15.3% | 23.6M-4.4% | ||
| Cash & equivalents | 25.9M+73.7% | 14.9M-30.2% | 21.4M+31.2% | 16.3M+13.2% | 14.4M-32.4% | |
| Accounts receivable | 11.8M+119.3% | 5.36M+57.2% | 3.41M+84.2% | 1.85M-66.1% | 5.47M+11297.9% | |
| Inventory | 15.4M+1.2% | 15.2M+1572.0% | 911K+63.6% | 557K+1.3% | 550K-55.7% | |
| Prepaid expenses | 7.46M+35.9% | 5.49M+386.4% | 1.13M-12.5% | 1.29M-59.4% | 3.18M+50.1% | |
| 92.1M+21.0% | 76.1M+139.8% | 31.7M+26.8% | 25.0M-8.9% | 27.5M+4.4% | ||
| Property, plant & equipment | 326K+858.8% | 34.0K-41.4% | 58.0K-19.4% | 72.0K-37.4% | 115K-85.8% | |
| Operating lease right-of-use | 310K+77.1% | 175K+90.2% | 92.0K-51.1% | 188K+80.8% | 104K-45.8% | |
| Intangible assets | 30.9M-11.5% | 34.9M+636.0% | 4.74M-0.3% | 4.75M+31.3% | 3.62M+529.7% | |
| Other non-current assets | 19.0K+58.3% | 12.0K+0.0% | 12.0K+0.0% | 12.0K-42.9% | 21.0K-47.5% | |
| 38.5M+93.0% | 19.9M+22.8% | 16.2M+151.4% | 6.46M+41.8% | 4.56M+20.1% | ||
| Accounts payable | 11.0M+163.4% | 4.17M+125.5% | 1.85M+4.6% | 1.77M-0.5% | 1.77M-24.3% | |
| Accrued liabilities | 9.41M+5.5% | 8.91M+65.5% | 5.39M+47.1% | 3.66M+168.1% | 1.37M+16.8% | |
| Short-term & current debt | 8.79M | 0.00-100.0% | 5.38M+420.8% | 1.03M-27.2% | 1.42M | |
| Current lease liability | 65.0K-14.5% | 76.0K+43.4% | 53.0K-29.3% | 75.0K | — | |
| 66.0M+27.6% | 51.7M+217.9% | 16.3M+36.1% | 12.0M+21.5% | 9.84M-7.7% | ||
| Long-term debt | 21.8M-27.0% | 29.8M | 0.00-100.0% | 5.38M+2.3% | 5.26M-19.4% | |
| Non-current lease liability | 460K+329.9% | 107K+386.4% | 22.0K-79.4% | 107K+613.3% | 15.0K-84.8% | |
| Operating lease liability (total) | 525K+186.9% | 183K+144.0% | 75.0K-58.8% | 182K | — | |
| Finance lease liability (total) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other non-current liabilities | 5.24M+186.4% | 1.83M | 0.00 | — | — | |
| 26.2M+7.1% | 24.4M+57.8% | 15.5M+18.3% | 13.1M-25.8% | 17.6M+0.0% | ||
| Common stock | 27.0K+0.0% | 27.0K+3.8% | 26.0K+4.0% | 25.0K+0.0% | 25.0K+4.2% | |
| Additional paid-in capital | 139M+4.8% | 132M+10.7% | 120M+2.9% | 116M+4.0% | 112M+3.6% | |
| Retained earnings | -112M-4.3% | -108M-3.7% | -104M-0.9% | -103M-9.6% | -94.1M-2.1% | |
| Total liabilities & equity | 92.1M+21.0% | 76.1M+139.8% | 31.7M+26.8% | 25.0M-8.9% | 27.5M+4.4% | |
| Common shares issued | 27.0M+1.3% | 26.7M+4.0% | 25.7M+1.3% | 25.4M+3.0% | 24.6M+1.3% | |
| Common shares outstanding | 27.0M+1.3% | 26.7M+4.0% | 25.7M+1.3% | 25.4M+3.0% | 24.6M+1.3% | |
| Shares outstanding (cover) | 27.3M+1.7% | 26.8M+4.4% | 25.7M+0.9% | 25.5M+3.4% | 24.6M+0.9% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 10.5M+986.1% | 969K-85.8% | 6.82M+41.4% | 4.82M+202.1% | -4.72M+78.9% | ||
| Depreciation & amortization | 4.04M+252.9% | 1.15M+27.2% | 901K+1265.2% | 66.0K-57.4% | 155K-55.3% | |
| Intangible amortization | 4.00M+265.2% | 1.10M+38.7% | 790K-51.1% | 1.62M+692.6% | 204K+36.0% | |
| Share-based compensation | 5.51M+74.2% | 3.17M+0.9% | 3.14M-25.6% | 4.22M+24.8% | 3.38M+31.3% | |
| Change in receivables | 6.40M+105.1% | 3.12M+100.0% | 1.56M+143.1% | -3.62M-166.7% | 5.42M+1376.0% | |
| Change in inventory | 5.88M+219.5% | 1.84M+398.4% | 369K+5171.4% | 7.00K+101.0% | -692K-180.3% | |
| Change in payables | 6.81M+193.7% | 2.32M+4273.6% | 53.0K+762.5% | -8.00K+98.6% | -570K-132.2% | |
| -333K+99.2% | -40.0M-5063.1% | -775K+72.2% | -2.79M-8.9% | -2.56M-5018.0% | ||
| Capital expenditure | 333K+1180.8% | 26.0K | 0.00-100.0% | 38.0K+322.2% | 9.00K-82.0% | |
| Free cash flow | 10.2M+980.7% | 943K-86.2% | 6.82M+42.5% | 4.78M+201.1% | -4.73M+78.9% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 815K-97.5% | 32.6M+3505.7% | -957K-614.2% | -134K-134.3% | 391K-98.8% | ||
| Long-term debt issued | 0.00-100.0% | 25.3M | 0.00 | 0.00 | 0.00-100.0% | |
| Long-term debt repaid | 0.00-100.0% | 1.16M+0.0% | 1.16M+200.0% | 385K | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | 11.0M+270.6% | -6.45M-226.9% | 5.08M+167.7% | 1.90M+127.6% | -6.89M-174.6% | |
| Interest paid | 3.33M+400.0% | 665K-21.0% | 842K+15.3% | 730K-10.4% | 815K+2.3% | |
| Income taxes paid | 118K+43.9% | 82.0K-66.8% | 247K | 0.00 | 0.00 | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 461M+29.2% | 357M+217.8% | 112M+57.5% | 71.3M-32.5% | 106M-46.8% | |
| P/E | — | — | 50.4× | — | — | |
| P/S | 5.8×-37.0% | 9.2×+167.5% | 3.4×-9.6% | 3.8×-21.8% | 4.8×-99.9% | |
| P/B | 17.6×+20.6% | 14.6×+119.8% | 6.7×+4.3% | 6.4×+6.5% | 6.0×-46.8% | |
| P/FCF | 45.3×-88.0% | 378.8×+3019.8% | 12.1× | — | — | |
| Earnings yield | — | — | 2.0% | — | — | |
| FCF yield | 2.2%+736.7% | 0.26%-96.8% | 8.2% | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: ETON’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ETON filings on SEC EDGAR → Not investment advice.